About Leadership Technology Investors Pipeline News Careers and Culture Contact Us Changing the future of Oncology. News Piper Sandler 33rd Annual Healthcare Conference – Presentation Nov 22, 2021 Webcast, Nov 22, 2021 at 10:00am EST Download Presentation, Click here read more Sutro Biopharma to Participate in Two Upcoming Investor Conferences Nov 22, 2021 SOUTH SAN FRANCISCO, Calif., Nov. 22, 2021 – Sutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage drug discovery, development and manufacturing company focused on the application of precise protein engineering and rational design to create next-generation cancer and... read more Jefferies London Healthcare Conference – Presentation Nov 17, 2021 Webcast: Nov 18, 2021 at 3:00am EST Download: Click Here read more Sutro Biopharma Announces Appointment of Heidi Hunter to Board of Directors Nov 17, 2021 - Heidi Hunter, accomplished healthcare leader and President of Cardinal Health Specialty Solutions, to bring additional global biopharma strategic and operational expertise to Sutro's Board - SOUTH SAN FRANCISCO, Nov. 17,2021 – Sutro Biopharma, Inc. (NASDAQ: STRO), a... read more Stifel 2021 Virtual Healthcare Conference – Presentation Nov 15, 2021 Webcast: Nov 15, 2021 at 1:20pm EST Download: Click Here read more Credit Suisse 30th Annual Healthcare Conference – Presentation Nov 10, 2021 Webcast, Nov 10, 2021 at 4:20pm EST Download Presentation, Click Here read more Sutro Biopharma Reports Third Quarter 2021 Financial Results, Business Highlights, and Anticipated 2021 Milestones Nov 10, 2021 - Patient enrollment has been completed for the STRO-002 Phase 1 ovarian cancer dose-expansion cohort, and an interim data update is expected in the second half of 2021 – - STRO-001 Phase 1 dose escalation for non-Hodgkin’s lymphoma and multiple myeloma is ongoing to... read more Sutro Biopharma to Participate in Three Upcoming Investor Conferences Nov 2, 2021 SOUTH SAN FRANCISCO, Calif., Nov. 2, 2021 – Sutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage drug discovery, development and manufacturing company focused on the application of precise protein engineering and rational design to create next-generation cancer and... read more Sutro Biopharma and BioNova Pharmaceuticals Enter into Collaboration for STRO-001 in Greater China Oct 12, 2021 SOUTH SAN FRANCISCO and SHANGHAI, China, Oct. 12, 2021 – Sutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage drug discovery, development and manufacturing company focused on the application of precise protein engineering and rational design to create... read more Sutro Biopharma Announces Extension of Cytokine Derivative Research Program Under Collaboration with Merck Sep 30, 2021 SOUTH SAN FRANCISCO, Sept. 30, 2021 – Sutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage drug discovery, development and manufacturing company focused on the application of precise protein engineering and rational design to create next-generation cancer and... read more « Older Entries 0 1 SUTRO BIOPHARMA 111 OYSTER POINT BLVD SOUTH SAN FRANCISCO, CA 94080 PHONE: 650-881-6500 FAX: 650-553-9659 GOOGLE MAP Tweets by @sutrobio CONTACT US GENERAL INQUIRES: GENERAL@SUTROBIO.COM BUSINESS INQUIRES: BUSDEV@SUTROBIO.COM INVESTOR RELATIONS INQUIRES: IR@SUTROBIO.COM CAREERS: JOBS@SUTROBIO.COM © 2021 Sutro Biopharma, Inc. – Privacy Policy